Copy
View this email in your browser
Vol. 3, No. 12                                                                                                         June 17, 2020

Cancer Institute Member Spotlight

Reid D. Landes, Ph.D.

Associate Professor
Department of Biostatistics
UAMS College of Medicine
As a statistician who collaborates with a variety of investigators, Dr. Landes' research endeavors are wide. With respect to statistics research, he currently works on statistical inference in N-of-1 trials and sample size calculations of “Effective Dose 50” or ED50 experiments. Read more>
2021 Medical Research Endowment Awards

Shuk-Mei Ho, Ph.D., vice chancellor for research and innovation, announces the 2020 Medical Research Endowment Awards granted by the UAMS Foundation Fund Board. Approximately $100,000 from the endowment income will be available for research projects in 2021.
 
The application deadline is 5 p.m. July 20, 2020. Submissions will be reviewed by the UAMS Research Committee (i.e., faculty members from the Colleges of Medicine, Nursing, Pharmacy, Public Health, Health Professions, Academic Senate and the Graduate School). Following reviews and recommendations, the UAMS Foundation Fund Board will approve the list of award recipients.
 
Please review the MRE online application form requirements carefully. Non-conforming applications will be returned without review. In addition, all applicable approvals (HRAC, biohazard, animal use, etc.) may be obtained after the grant has been approved by the UAMS Foundation Fund Board, but must be complete before funds are awarded. The review process should be complete by September 30, 2020 so work may begin January 1, 2021.

Findings on DNA Damage Repair Published by UAMS Cancer Researcher


A research team led by cancer researcher Justin Leung, Ph.D., at the University of Arkansas for Medical Sciences (UAMS) has uncovered the role of the protein RNF168 in DNA damage repair and shown how mutations of the protein affect people with a rare genetic condition.

The study titled “Histone H2A variants alpha1-extension helix directs RNF168-mediated ubiquitination” was published in the May 18 issue of the open-access journal Nature Communications. Read more>

Cancer-related Research Funding Opportunities
Extramural Opportunities

Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)  

Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)

Integrating Biospecimen Science Approaches into Clinical Assay Development

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
DoD Lung Cancer, Career Development Award

DoD Lung Cancer, Investigator-Initiated Translational Research Award

DoD Lung Cancer, Clinical Translational Research Partnership Award
 
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)

DOD Prostate Cancer, Early Investigator Research Award

DoD Prostate Cancer, Health Disparity Research Award

DoD Prostate Cancer, Clinical Trial Award

DoD Prostate Cancer, Translational Science Award

DoD Prostate Cancer, Population Science and Outcomes Research Award

DoD Prostate Cancer, Idea Development Award

DoD Prostate Cancer, Prostate Cancer Pathology Resource Network Award

DoD Prostate Cancer, Physician Research Award

Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)

DoD Neurofibromatosis, Investigator-Initiated Research Award

DoD Neurofibromatosis, Clinical Trial Award

DoD Neurofibromatosis, Exploration – Hypothesis Development Award

DoD Neurofibromatosis, New Investigator Award

DoD Neurofibromatosis, Early Investigator Research Award

DoD Neurofibromatosis, Synergistic Idea Award

DoD, Breast Cancer, Breakthrough Award Levels 1 and 2

DoD, Breast Cancer, Breakthrough Award Level 3

DoD, Breast Cancer, Breakthrough Award Level 4

DoD, Breast Cancer, Innovator Award

DoD Breast Cancer, Era of Hope Scholar Award

DoD Breast Cancer, Transformative Breast Cancer Consortium Award

DoD Melanoma Research Program, Idea Award

DoD Melanoma Research Program, Mid-Career Accelerator Award

DoD Melanoma Research Program, Team Science Award

DoD Melanoma Research Program, Technology Development Partnership Award

DoD Melanoma Research Program, Translational Research Award

DoD Melanoma Research Program, Translational Research Award – Collaborator Option

DoD CDMRP Ovarian Cancer Research Program Ovarian Cancer Academy – Early-Career Investigator Award

DoD CDMRP Ovarian Cancer Research Program Clinical Translational Research Award

DoD CDMRP Ovarian Cancer Research Program Pilot Award

DoD CDMRP Ovarian Cancer Research Program Investigator-Initiated Research Award
 
DoD CDMRP Ovarian Cancer Proteogenomics Research Award

DoD Academy of Kidney Cancer Investigators – Early Career Investigator Award

DoD Kidney Cancer Research Program Concept Award

DoD Kidney Cancer Research Program Translational Research Partnership Award

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01)

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)

NIH Utilizing Cohort Studies to Address Outcomes in Cancer Survivors

 

CTSA Supplemental Funding Opportunities

NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)


 
Foundation and Intramural Funding Opportunities

American Association for Cancer Research Invites Applications for Research Training Grants

UAMS Medical Research Endowment Awards

Damon Runyon Cancer Research Foundation Invites Applicants for Innovative Research

Children’s Leukemia Research Association Invites Applications for Research
 
Know someone who needs to be added to our email list? Send their name to Susan Van Dusen, communications manager.
Copyright © 2021 *|LIST:COMPANY|*, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp